 Shares of Leap Therapeutics Inc NASDAQ:LPTX have earned an average rating of Buy from the seven analysts that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12-month price objective among brokerages that ... 